Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

Improving Memory in Patients With Multiple Sclerosis
Interventions to Improve Memory in Patients With Multiple Sclerosis
Status: Archived
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Improving Memory in Patients With Multiple Sclerosis
Interventions to Improve Memory in Patients With Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis
Status: Archived
Oregon Health and Science University
mi
from
Portland, OR
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Improving New Learning and Memory in Multiple Sclerosis
Improving New Learning in Multiple Sclerosis: A Randomized Clinical Trial
Status: Archived
Kessler Foundation Research Center
mi
from
West Orange, NJ
Improving New Learning and Memory in Multiple Sclerosis
Improving New Learning in Multiple Sclerosis: A Randomized Clinical Trial
Status: Archived
Updated: 1/1/1970
Kessler Foundation Research Center
mi
from
West Orange, NJ
Pregnancy Exposure Registry for AVONEX
Pregnancy Exposure Registry for AVONEX
Status: Archived
Kendle International Inc.
mi
from
Wilmington, NC
Pregnancy Exposure Registry for AVONEX
Pregnancy Exposure Registry for AVONEX
Status: Archived
Updated: 1/1/1970
Kendle International Inc.
mi
from
Wilmington, NC
Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness
Treadmill Training in Chronic MS: Efficacy and Cost-Effectiveness
Status: Archived
VA Maryland Health Care System
mi
from
Baltimore, MD
Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness
Treadmill Training in Chronic MS: Efficacy and Cost-Effectiveness
Status: Archived
Updated: 1/1/1970
VA Maryland Health Care System
mi
from
Baltimore, MD
Ambulation Study in Multiple Sclerosis
A Prospective Study of Clinical Indices as Predictors of Ambulatory Effectiveness in Multiple Sclerosis
Status: Archived
MS Center at Evergreen
mi
from
Kirkland, WA
Ambulation Study in Multiple Sclerosis
A Prospective Study of Clinical Indices as Predictors of Ambulatory Effectiveness in Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
MS Center at Evergreen
mi
from
Kirkland, WA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
North Central Neurology Associates, PC
mi
from
Cullman, AL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
North Central Neurology Associates, PC
mi
from
Cullman, AL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
The Research & Education Inst. of Alta Bates Summit Med. Group
mi
from
Berkeley, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
The Research & Education Inst. of Alta Bates Summit Med. Group
mi
from
Berkeley, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neuro-Pain Medical Center
mi
from
Fresno, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neuro-Pain Medical Center
mi
from
Fresno, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Moores Cancer Center
mi
from
La Jolla, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Moores Cancer Center
mi
from
La Jolla, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Yale New Haven Medical Center
mi
from
New Haven, CT
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Yale New Haven Medical Center
mi
from
New Haven, CT
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Georgetown Univ Med Ctr
mi
from
Washington,
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Georgetown Univ Med Ctr
mi
from
Washington,
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Miami Hospital
mi
from
Miami, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
mi
from
Miami, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neurological Associates
mi
from
Pompano Beach, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neurological Associates
mi
from
Pompano Beach, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neurology Consultants of Burlington County
mi
from
Lumberton, NJ
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neurology Consultants of Burlington County
mi
from
Lumberton, NJ
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
AMO Corporation
mi
from
Tallahassee, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
AMO Corporation
mi
from
Tallahassee, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
MS Center of Vero Beach
mi
from
Vero Beach, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
MS Center of Vero Beach
mi
from
Vero Beach, FL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
South Suburban Neurology
mi
from
Flossmoor, IL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
South Suburban Neurology
mi
from
Flossmoor, IL
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neorological Associates
mi
from
Richmond, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neorological Associates
mi
from
Richmond, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Mercy Ruan Neurology Clinic Res Ct.
mi
from
Des Moines, IA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Mercy Ruan Neurology Clinic Res Ct.
mi
from
Des Moines, IA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Kansas Medical Center
mi
from
Kansas City, KA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Kansas Medical Center
mi
from
Kansas City, KA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Maryland, Baltimore
mi
from
Baltimore, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Maryland, Baltimore
mi
from
Baltimore, MD
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Caritas St. Elizabeth Medical Center
mi
from
Brighton, MA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Caritas St. Elizabeth Medical Center
mi
from
Brighton, MA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Springfield Neurology Associates, LLC
mi
from
Springfield, MA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Springfield Neurology Associates, LLC
mi
from
Springfield, MA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Spectrum Health Medical Group, Neurology
mi
from
Grand Rapids, MI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Spectrum Health Medical Group, Neurology
mi
from
Grand Rapids, MI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Saint Luke's Hospital
mi
from
Chesterfield, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Saint Luke's Hospital
mi
from
Chesterfield, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
The MS Center for Innovation in Care
mi
from
St. Louis, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
The MS Center for Innovation in Care
mi
from
St. Louis, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of New Mexico
mi
from
Albuquerque, NM
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of New Mexico
mi
from
Albuquerque, NM
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Island Neurological Associates
mi
from
Plainview, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Island Neurological Associates
mi
from
Plainview, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Toledo Health Science Campus
mi
from
Toledo, OH
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Toledo Health Science Campus
mi
from
Toledo, OH
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neurological Associates of Tulsa, Inc
mi
from
Tulsa, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neurological Associates of Tulsa, Inc
mi
from
Tulsa, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Vanderbilt University Medical Center
mi
from
Ventura, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Ventura, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Univ of Texas Galveston
mi
from
Galveston, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Univ of Texas Galveston
mi
from
Galveston, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Integra Clinical Research
mi
from
San Antonio, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Integra Clinical Research
mi
from
San Antonio, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Seattle Neuroscience Institute/Swedish Medical, 550 17th Avenue, Suite 500
mi
from
Seattle, WA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Seattle Neuroscience Institute/Swedish Medical, 550 17th Avenue, Suite 500
mi
from
Seattle, WA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Wisconsin-Madison
mi
from
Madison, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison
mi
from
Madison, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Saint Luke's/ Mid-America Heart Institute
mi
from
Kansas City, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Saint Luke's/ Mid-America Heart Institute
mi
from
Kansas City, MO
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Comparison of Standard 1.5 Versus 3T Optimized Protocols in Patients Treated With Glatiramer Acetate. A Conventional and Non-Conventional MRI Study
Status: Archived
University at Buffalo - Buffalo General Hospital
mi
from
Buffalo, NY
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Comparison of Standard 1.5 Versus 3T Optimized Protocols in Patients Treated With Glatiramer Acetate. A Conventional and Non-Conventional MRI Study
Status: Archived
Updated: 1/1/1970
University at Buffalo - Buffalo General Hospital
mi
from
Buffalo, NY
Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor
Use of Two DBS Electrodes to Treat Post-Traumatic Tremor
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor
Use of Two DBS Electrodes to Treat Post-Traumatic Tremor
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL